News

IOCB Tech shines spotlight on cutting-edge innovations at BioVaria conference

24/04/2023
IOCB Tech proudly participated in the prestigious BioVaria Conference held in Munich, Germany. This renowned conference, dedicated to fostering innovation in the life sciences sector uniting potential licensees and investors from the biotech and pharmaceutical industry with scientists, founders, and technology transfer experts from all over Europe. Read more

IOCB Tech showcases cutting-edge innovations at Bio Europe Spring 2023

20/03/2023
IOCB Tech is excited to announce its participation in the highly anticipated Bio Europe Spring 2023 conference, taking place in Base, Switzerland. This conference brings together influential leaders, entrepreneurs, investors, and innovators in the biotech and pharmaceutical industries, creating a dynamic platform for collaboration and innovation. Read more

Czech science will be supported by a new foundation

09/05/2022
The aim of the newly established IOCB Tech Foundation is to support the long-term development of research, the transfer of new knowledge into practice and the popularisation of science. Read more

Financial support to Ukrainian scientists

25/02/2022
The Neuron Endowment Fund, Neuron patrons, and IOCB Tech have joined forces to provide active support to young Ukrainian scientists during the current crisis. Read more

Czech science to receive hundreds of millions

26/01/2022
IOCB Tech will distribute approximately CZK 250 million to support Czech science, research and innovation next year. Read more

New coronavirus protective antibody test

08/09/2021
New coronavirus protective antibody test license to Immunotech, a subsidiary of Beckman Coulter. We are so proud to be a part of the kit development. All our tech transfer expertise has been successfully implied in the process. Read more

IOCB Tech donates kits for 10,000 covid-19 tests

10/07/2020
IOCB Tech has donated kits for 10,000 isolations of viral RNA for COVID-19 testing to Public Health Institute Ostrava at a total value of 780,000 CZK (c. 30,000 EUR). Read more

MediAim – new therapeutic strategies

25/06/2020
All team of IOCB Tech is proud that IOCB Prague has become one of the strategic institutes in the MediAim consortium, which brings together three centers of excellence in science, research, and clinical practice. Read more

Viral RNA isolation kits developed at IOCB and RCPTM

01/06/2020
Researchers from RCPTM and IOCB Tech have developed a new method for isolating viral RNA independent of commercially available materials. The production is being transferred to IOCB Tech, which will oversee distribution in the Czech Republic and Slovakia. Read more